Some mushrooms have been known to exhibit several medicinal properties for thousands of years in Japanese and other Asian cultures. The Reishi mushroom, also known as Ganoderma lucidum, is well characterized (in Traditional Chinese Medicine) for the prevention and treatment of several disease states such as cancer, allergies and asthma. In the west, Reishi is commonly sold in the extract form. This study shows the difference in the concentration of both enzymes and beta-glucans between one Reishi extract sample and one Reishi biomass sample.
Keyword glucose-2-oxidase
back to clinical articlesDisplaying 1 - 4 of 4 clinical articles tagged with this topic.
Download PDF
Download PDF
In this two page article, Professor Amin Karmali discusses the role of enzyme content in the biomass form of Ganoderma lucidum (Reishi) and potential use in histamine mediated allergic response ie. Hayfever. The article compares the enzyme content of an extracted form of Reishi when compared to the biomass form of Reishi when both forms are exposed (in vitro) to digestive enzymes.
Download PDF
“Cancer Prevention with Supplementation of Diets with Botanicals”
by Karmali, A. and Fernandes, T.H.
Download PDF
ESCVN/ ECVCN – 5 – 7th October 2006 - Nantes
This work was conducted with a mushroom (Coriolus versicolor) which is in the market for human and animal use. Mushroom polysaccharides, particularly ß-glucans, have antitumour and immunomodulating properties.
Download PDF
The Role of Mushroom Nutrition as A Delivery Agent for Enzyme Therapy in Cancer Care?
Chemical and Biological Properties in Mushroom Nutrition
In this abstract, Professor Karmali examines the in vitro content of lacasse activity, protease activity, peroxidase activity and glycomylase activity (glycose-2-oxidase) of various mushrooms (Grifola frondosa, Ganoderma lucidium, Cordyceps sinensis and Coriolus versicolor ) per 500 mg tablet.